PeptideStack
5.2kquestions
20kanswers
220users

Is 2.5 mg in 2.5 mL of 0.9% sodium chloride a sensible presentation for a GLP-1 receptor agonist?

Asked 26 Dec 2025Modified 7 months agoViewed 4.4k times
17

Conditions: 2.5 mg · 2.5 mL · 0.9% sodium chloride · a GLP-1 receptor agonist.

I want to decide this in advance so that I am not deciding it under pressure later.

Assume I will follow the plan I write down, so I would like it to be a good one.

How would you structure this, and what thresholds would you set in advance?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questionsreconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questionsdosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
GH
askedgreta_holzmann15k1826 Dec 2025
2Confirming from the other direction: I did the wrong thing and got exactly the predicted outcome. – lyoph_cake 3 months ago
Is there a reason to prefer the second method over the first, other than cost? – rota_site 42 days ago
add a comment

No answers yet

This question has not been answered. It has been viewed 4.4k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.